News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
778,302 Results
Type
Article (52364)
Company Profile (372)
Press Release (725547)
Multimedia
Podcasts (166)
Webinars (25)
Section
Business (219176)
Career Advice (2595)
Deals (37902)
Drug Delivery (140)
Drug Development (86066)
Employer Resources (184)
FDA (17380)
Job Trends (16345)
News (370852)
Policy (35743)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2899)
Accelerated approval (33)
Adcomms (33)
Allergies (150)
Alliances (54358)
ALS (182)
Alzheimer's disease (1777)
Antibody-drug conjugate (ADC) (345)
Approvals (17595)
Artificial intelligence (590)
Autoimmune disease (169)
Automation (41)
Bankruptcy (386)
Best Places to Work (12316)
BIOSECURE Act (22)
Biosimilars (203)
Biotechnology (222)
Bladder cancer (163)
Brain cancer (62)
Breast cancer (671)
Cancer (5037)
Cardiovascular disease (436)
Career advice (2193)
Career pathing (40)
CAR-T (305)
CDC (53)
Celiac Disease (2)
Cell therapy (805)
Cervical cancer (36)
Clinical research (73120)
Collaboration (1866)
Company closure (4)
Compensation (1178)
Complete response letters (70)
COVID-19 (2941)
CRISPR (101)
C-suite (900)
Cystic fibrosis (154)
Data (6354)
Decentralized trials (2)
Denatured (67)
Depression (148)
Diabetes (523)
Diagnostics (7066)
Digital health (52)
Diversity (13)
Diversity, equity & inclusion (47)
Drug discovery (280)
Drug pricing (220)
Drug shortages (34)
Duchenne muscular dystrophy (241)
Earnings (94218)
Editorial (64)
Employer branding (22)
Employer resources (165)
Events (127223)
Executive appointments (1033)
FDA (20581)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1560)
Gene editing (217)
Generative AI (52)
Gene therapy (658)
GLP-1 (1095)
Government (5165)
Grass and pollen (7)
Guidances (385)
Healthcare (20260)
HIV (61)
Huntington's disease (47)
IgA nephropathy (87)
Immunology and inflammation (285)
Immuno-oncology (65)
Indications (111)
Infectious disease (3234)
Inflammatory bowel disease (203)
Inflation Reduction Act (17)
Influenza (123)
Intellectual property (257)
Interviews (451)
IPO (17320)
IRA (61)
Job creations (4385)
Job search strategy (1829)
JPM (71)
Kidney cancer (16)
Labor market (87)
Layoffs (628)
Leadership (39)
Legal (8842)
Liver cancer (96)
Longevity (15)
Lung cancer (675)
Lymphoma (386)
Machine learning (44)
Management (64)
Manufacturing (857)
MASH (177)
Medical device (14491)
Medtech (14548)
Mergers & acquisitions (21651)
Metabolic disorders (1384)
Multiple sclerosis (165)
NASH (21)
Neurodegenerative disease (353)
Neuropsychiatric disorders (102)
Neuroscience (3102)
Neurotech (1)
NextGen: Class of 2026 (7160)
Non-profit (4947)
Now hiring (67)
Obesity (669)
Opinion (318)
Ovarian cancer (170)
Pain (218)
Pancreatic cancer (236)
Parkinson's disease (302)
Partnered (38)
Patents (514)
Patient recruitment (510)
Peanut (60)
People (62983)
Pharmaceutical (101)
Pharmacy benefit managers (33)
Phase 1 (22745)
Phase 2 (32088)
Phase 3 (24092)
Pipeline (5409)
Policy (329)
Postmarket research (2758)
Preclinical (9699)
Press Release (69)
Prostate cancer (246)
Psychedelics (55)
Radiopharmaceuticals (297)
Rare diseases (923)
Real estate (6693)
Recruiting (75)
Regulatory (26409)
Reports (53)
Research institute (2641)
Resumes & cover letters (419)
Rett syndrome (28)
RNA editing (20)
RSV (85)
Schizophrenia (161)
Series A (261)
Series B (202)
Service/supplier (13)
Sickle cell disease (102)
Special edition (25)
Spinal muscular atrophy (169)
Sponsored (45)
Startups (4015)
State (2)
Stomach cancer (19)
Supply chain (110)
Tariffs (98)
The Weekly (97)
Vaccines (1137)
Venture capital (99)
Weight loss (454)
Women's health (94)
Worklife (22)
Date
Last 7 days (642)
Last 30 days (2118)
Last 365 days (31410)
2026 (3622)
2025 (31853)
2024 (36966)
2023 (41918)
2022 (53288)
2021 (57910)
2020 (56652)
2019 (49909)
2018 (37837)
2017 (34745)
2016 (34737)
2015 (40811)
2014 (34506)
2013 (29574)
2012 (31619)
2011 (32254)
2010 (30144)
Location
Africa (925)
Alabama (89)
Alaska (7)
Arizona (327)
Arkansas (14)
Asia (44825)
Australia (7310)
California (11574)
Canada (3345)
China (1172)
Colorado (491)
Connecticut (494)
Delaware (347)
Europe (99534)
Florida (1722)
Georgia (368)
Hawaii (3)
Idaho (66)
Illinois (924)
India (70)
Indiana (541)
Iowa (23)
Japan (444)
Kansas (130)
Kentucky (42)
Louisiana (27)
Maine (83)
Maryland (1434)
Massachusetts (8463)
Michigan (343)
Minnesota (659)
Mississippi (6)
Missouri (141)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (83)
New Jersey (3102)
New Mexico (30)
New York (3068)
North Carolina (1578)
North Dakota (10)
Northern California (5624)
Ohio (352)
Oklahoma (23)
Oregon (47)
Pennsylvania (2315)
Puerto Rico (25)
Rhode Island (48)
South America (1312)
South Carolina (68)
South Dakota (1)
Southern California (4509)
Tennessee (178)
Texas (1805)
United States (41542)
Utah (348)
Vermont (1)
Virginia (286)
Washington D.C. (84)
Washington State (962)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
778,302 Results for "par pharmaceutical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Par Health Names Dr. William Larkins as EVP and Chief Scientific Officer and President, Sterile Injectables
January 12, 2026
·
5 min read
Press Releases
Par Health Completes Spin-Off from Mallinckrodt, Creating an Independent Leader in Generic Pharmaceuticals and Sterile Injectables
November 10, 2025
·
7 min read
Press Releases
Mallinckrodt Completes Spin-Off of Par Health, Introduces Keenova Therapeutics
November 10, 2025
·
11 min read
Press Releases
Par Health Reports Third Quarter 2025 Financial Results and Provides Business Update
November 10, 2025
·
19 min read
Press Releases
Dechra Announces FDA Approval of Zygolide® (pergolide tablets) for the Control of Clinical Signs Associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing’s Disease) in Horses
January 5, 2026
·
3 min read
Press Releases
HSS Researchers Report Benefits of Robotic-Assisted Spine Surgery for Adolescent Athletes with Back Pain Due to Pars Fractures
November 17, 2025
·
5 min read
Press Releases
Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™
February 13, 2026
·
12 min read
Press Releases
60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio
January 16, 2026
·
6 min read
Press Releases
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering
January 12, 2026
·
3 min read
Press Releases
Aucta Pharmaceuticals, Inc. (“Aucta Pharmaceuticals”) prepares for the launch of PYQUVI™ (deflazacort) oral suspension, the first of a new branded-generic rare disease product line
February 8, 2026
·
7 min read
1 of 77,831
Next
